InvestSMART

Neuren Pharmaceuticals Limited (ASX: NEU) - Announcements

Current share price for NEU : $20.220 0.38 (1.84%)+

ASX company news and announcements for Neuren Pharmaceuticals Limited (NEU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neuren Pharmaceuticals Limited (NEU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neuren Pharmaceuticals Limited (NEU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neuren Pharmaceuticals Limited (NEU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,563 First site initiated for Neuren's PMS Phase 3 trial 25 Aug 2025 9:27AM $17.170 $20.220 risen by 17.76%
$2,563 Application for quotation of securities - NEU 12 Aug 2025 4:12PM $17.880 $20.220 risen by 13.09%
$2,563 Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline 8 Aug 2025 9:16AM $17.550 $20.220 risen by 15.21%
$2,563 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $20.220 risen by 18.87%
$2,563 DAYBUE Q2 2025 net sales US$96.1 million up 14% from Q2 2024 7 Aug 2025 9:51AM $17.010 $20.220 risen by 18.87%
$2,563 Change of Director's Interest Notice - J Pilcher 22 Jul 2025 9:30AM $15.170 $20.220 risen by 33.29%
$2,563 Application for quotation of securities - NEU 22 Jul 2025 9:21AM $15.170 $20.220 risen by 33.29%
$2,563 Notification regarding unquoted securities - NEU 9 Jul 2025 5:03PM $14.180 $20.220 risen by 42.60%
$2,563 Application for quotation of securities - NEU 30 Jun 2025 5:49PM $14.110 $20.220 risen by 43.30%
$2,563 US patent allowed for NNZ-2591 to treat Pitt Hopkins 26 Jun 2025 9:25AM $12.540 $20.220 risen by 61.24%
$2,563 Notification of cessation of securities - NEU 25 Jun 2025 5:26PM $12.540 $20.220 risen by 61.24%
$2,563 Update - Notification of buy-back - NEU 16 Jun 2025 9:28AM $13.100 $20.220 risen by 54.35%
$2,563 Update - Notification of buy-back - NEU 16 Jun 2025 9:07AM $13.100 $20.220 risen by 54.35%
$2,563 Update - Notification of buy-back - NEU 13 Jun 2025 8:26AM $13.900 $20.220 risen by 45.47%
$2,563 Update - Notification of buy-back - NEU 12 Jun 2025 7:45AM $13.830 $20.220 risen by 46.20%
$2,563 Update - Notification of buy-back - NEU 11 Jun 2025 8:07AM $13.990 $20.220 risen by 44.53%
$2,563 Update - Notification of buy-back - NEU 10 Jun 2025 8:33AM $13.760 $20.220 risen by 46.95%
$2,563 Update - Notification of buy-back - NEU 6 Jun 2025 9:13AM $13.900 $20.220 risen by 45.47%
$2,563 Update - Notification of buy-back - NEU 5 Jun 2025 7:50AM $13.900 $20.220 risen by 45.47%
$2,563 Notification of cessation of securities - NEU 4 Jun 2025 4:30PM $13.900 $20.220 risen by 45.47%
$2,563 Update - Notification of buy-back - NEU 4 Jun 2025 8:30AM $13.710 $20.220 risen by 47.48%
$2,563 Update - Notification of buy-back - NEU 3 Jun 2025 8:38AM $13.570 $20.220 risen by 49.01%
$2,563 Update - Notification of buy-back - NEU 2 Jun 2025 8:51AM $13.880 $20.220 risen by 45.68%
$2,563 Update - Notification of buy-back - NEU 30 May 2025 8:41AM $14.130 $20.220 risen by 43.10%
$2,563 Update - Notification of buy-back - NEU 29 May 2025 8:00AM $13.810 $20.220 risen by 46.42%

76 - 100 of 831 results

Page 4 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.